The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis-Reference-Cited by-同舟云学术

The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis

Published:2021-05 Issue:5 Volume:9 Page:e620-e627
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Phillips Andrew N,Bansi-Matharu Loveleen,Cambiano Valentina,Ehrenkranz Peter,Serenata Celicia,Venter Francois,Pett Sarah,Flexner Charles,Jahn Andreas,Revill Paul,Garnett Geoff P

Funder

Johnson and Johnson

Medical Research Council

Merck

South African Medical Research Council

Roche

European and Developing Countries Clinical Trials Partnership

Gilead Sciences

Bill and Melinda Gates Foundation

Gilead UK and Ireland Corporate Contributions

National Institutes of Health

Cilag

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Update of recommendations on first- and second-line antiretroviral regimens,2019

2. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial;Margolis;Lancet,2017

3. Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression;Swindells;N Engl J Med,2020

4. Long-acting cabotegravir and rilpivirine after oral induction for HIV-1 infection;Orkin;N Engl J Med,2020

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda;BMC Infectious Diseases;2024-08-28

2. Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses;PharmacoEconomics;2024-08-07

3. The long wait for long-acting HIV prevention and treatment formulations;The Lancet HIV;2024-08

4. Enhancing HIV treatment and support: a qualitative inquiry into client and healthcare provider perspectives on differential service delivery models in Uganda;AIDS Research and Therapy;2024-07-27

5. Challenges for Novel Antiretroviral Development in an Era of Widespread tenofovir-disoproxil/lamivudine (or emtricitabine)/dolutegravir availability (TLD) Availability;Clinical Infectious Diseases;2024-07-11